South Korea has published a new set of guidelines and updated five existing ones on the development, testing and approval of medical products that use AI and other digital technologies. These guidelines were adopted following the implementation of the Digital Medical Products Act on 24 January 2025, which establishes a comprehensive framework for managing, manufacturing and importing digital medical products.
Click here for the official article/release
Disclaimer
The Legal Wire takes all necessary precautions to ensure that the materials, information, and documents on its website, including but not limited to articles, newsletters, reports, and blogs (“Materials”), are accurate and complete. Nevertheless, these Materials are intended solely for general informational purposes and do not constitute legal advice. They may not necessarily reflect the current laws or regulations. The Materials should not be interpreted as legal advice on any specific matter. Furthermore, the content and interpretation of the Materials and the laws discussed within are subject to change.
